Genomind to Offer Psychiatric PGx Test to Early-Adopter Physicians
April 20, 2011
Genomind to Offer Psychiatric PGx Test to Early-Adopter Physicians
Genomind said the Genecept Mood Assay can help doctors "be more selective regarding medication choice and lessen the experimentation and guesswork often associated with determining appropriate medication."
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Genomind To Use DNA Genotek Collection Kit In Psychiatric Genetic Test
April 18, 2011 / GenomeWeb Daily News - New Products: CLC Bio's MedQL Variant Prioritizer; DNA Genotek's GenoFind Services
November 14, 2012 / Clinical Sequencing News - MDx/CDx Focus: PGXL's PerMIT Garners Patent; Baptist, Vanderbilt's Cancer Research Pact
November 2, 2012 / Pharmacogenomics Reporter - Genomind Launches Open Label Study for PGx-Guided Psychiatric Therapy
May 16, 2012 / Pharmacogenomics Reporter - New Products: Courtagen's mtSEEKPDx; RainDance's Cancer Panel and More
April 4, 2012 / Clinical Sequencing News